Abstract:Objectives MicroRNAs, as one of key regulators for post-transcriptional gene control, have shown to be involved in cardiovascular diseases. This study aimed to investigate the roles of miR-378 in regulation of cardiac hypertrophy and cardiac fibrosis stimulated by pressure overload. Methods To construct cardiac remodelling mice models, pressure overload was imposed on the heart of C57B/L6 mice (8 weeks) by constriction of transverse aortic banding (TAC). Chemically modified oligonucleotides miRNA mimics (miR-378-Agomir) and inhibitors (miR-378-Antagomir) treatment started 24 h after TAC by intravenous injections on two consecutive days. Mice were randomly divided into four groups: 1) the TAC group; 2) the TAC-Agomir group; 3) the TAC- Antagomir group; 4) the Sham operation group. Mice after sham or 2 weeks TAC operation were subjected to hemodynamic and echocardiographic measurement. Tissue and serum miR-378 expressions were detected by TaqMan MicroRNA Assay Kit. ANP, BNP, β-MHC, collagen I and collagen III was measured by Real-time PCR. ERK1/2, p-ERK1/2, MMPs and α-SMA expression were analysed by western blotting. Collagen was assessed by immunohistochemistry. Results We found that miR-378 has a high expression pattern in the heart. After two-week acute pressure overload, the TAC group exhibit prominent cardiac hypertrophic responses and decreased expression of miR-378(p < 0.05) comparing with the sham group. In vivo overexpression of miR-378 in TAC-Agomir group markerly inhibited cardiac hypertrophy, accompanied with downregulation of fetal gene ANP, BNP and β-MHC compared to that of TAC group. Howerver, inhibition of endogenous miR-378 by an infusion of an antagomir caused sustained cardiac hypertrophy, associated with a reinduction of fetal gene expression to a less extent. The p-ERK level was also downregulated in TAC-Agomir group and upregulated in TAC- Antagomir group. In part of cardiac fibrosis, we found that the over-expression of miR-378 of TAC-Agomir group reduced the expression of col I, col III, MMP2, MMP9 and α-SMA(p < 0.05) compared to that of TAC group, whereas down regulation of endogenous miR-378 with anti-miRs promoted collagens and MMPs expression. Conclusions These findings reveal orchestrating regulatory roles for miR-378 in pressure-overload induced cardiac remodeling. It suggests that miR-378 not only suppresses cardiac hypertrophy by regulating fetal genes expression and ERK1/2 signaling pathway but also controls fibrosis-related genes expression in the heart.

Mechanism of Cardiac Hypertrophy Regulates by miR-30e

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

LncRNA TUG1 Alleviates Cardiac Hypertrophy by Targeting Mir‐34a/dkk1/wnt‐β‐catenin Signalling

Attenuation of Microrna-1 Derepresses the Cytoskeleton Regulatory Protein Twinfilin-1 to Provoke Cardiac Hypertrophy

Targeting Mir-30D Reverses Pathological Cardiac Hypertrophy

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

miR‐31‐5p suppresses myocardial hypertrophy by targeting Nfatc2ip

Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a

GW24-e2270 MicroRNA-378 Plays Regulatory Roles in Pressure Overload-induced Cardiac Remodelling

MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.

Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats

MicroRNAs target gene and signaling pathway by bioinformatics analysis in the cardiac hypertrophy.

The changes of microRNAs expression in rat cardiac hypertrophy

Mir-1393 p is related to left ventricular hypertrophy and cardiomyocyte apoptosis in two-kidney one-clip hypertensive rats

MicroRNA-101 Inhibits Rat Cardiac Hypertrophy by Targeting Rab1a.

MicroRNA-30 Regulates Left Ventricular Hypertrophy in Chronic Kidney Disease

MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3

MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.

MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts.

MicroRNA-29a-3p Attenuates ET-1-induced Hypertrophic Responses in H9c2 Cardiomyocytes

The role of lncRNAKCNQ1OT1/miR-301b/Tcf7 axis in cardiac hypertrophy